The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Toshiro Kageshita

Department of Dermatology

Kumamoto University School of Medicine

Japan

[email]@*.*.kumamoto-u.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Dermatology, Kumamoto University School of Medicine, Japan. 1997 - 2003

References

  1. Widespread expression of parathyroid hormone-related peptide in melanocytic cells. Kageshita, T., Ishihara, T., Tokuo, H., Funasaka, Y., Ichihashi, M., Dong, J., Nakajima, M., Ono, T. Br. J. Dermatol. (2003) [Pubmed]
  2. Spontaneous regression of congenital melanocytic nevi without evidence of the halo phenomenon. Kageshita, T., Inoue, Y., Ono, T. Dermatology. (Basel) (2003) [Pubmed]
  3. Differential expression of tissue factor and tissue factor pathway inhibitor in metastatic melanoma lesions. Kageshita, T., Funasaka, Y., Ichihashi, M., Ishihara, T., Tokuo, H., Ono, T. Pigment Cell Res. (2002) [Pubmed]
  4. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Kageshita, T., Kashio, Y., Yamauchi, A., Seki, M., Abedin, M.J., Nishi, N., Shoji, H., Nakamura, T., Ono, T., Hirashima, M. Int. J. Cancer (2002) [Pubmed]
  5. Clinical significance of MART-1 and HLA-A2 expression and CD8+ T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients. Kageshita, T., Kawakami, Y., Ono, T. J. Dermatol. Sci. (2001) [Pubmed]
  6. Tissue factor expression and serum level in patients with melanoma does not correlate with disease progression. Kageshita, T., Funasaka, Y., Ichihashi, M., Wakamatsu, K., Ito, S., Ono, T. Pigment Cell Res. (2001) [Pubmed]
  7. Loss of beta-catenin expression associated with disease progression in malignant melanoma. Kageshita, T., Hamby, C.V., Ishihara, T., Matsumoto, K., Saida, T., Ono, T. Br. J. Dermatol. (2001) [Pubmed]
  8. Low frequency of neutralizing antibodies against natural interferon-beta during adjuvant therapy for Japanese patients with melanoma. Kageshita, T., Yamamoto, A., Yamazaki, N., Ishihara, K., Ono, T. J. Dermatol. Sci. (1999) [Pubmed]
  9. Hypercalcaemia in melanoma patients associated with increased levels of parathyroid hormone-related protein. Kageshita, T., Matsui, T., Hirai, S., Fukuda, Y., Ono, T. Melanoma Res. (1999) [Pubmed]
  10. Molecular genetic analysis of HLA class II alleles in Japanese patients with melanoma. Kageshita, T., Naruse, T., Hirai, S., Ono, T., Horikoshi, T., Nakagawa, H., Tamaki, K., Hayashibe, K., Ichihashi, M., Nakayama, J., Hori, Y., Ozawa, A., Miyahara, M., Ohkido, M., Inoko, H. Tissue. Antigens (1997) [Pubmed]
 
WikiGenes - Universities